198 related articles for article (PubMed ID: 33570630)
1. Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
Rai P; Joshi VM; Goldberg JF; Yates AM; Okhomina VI; Penkert R; Ataga KI; Kang G; Hankins JS
Blood Adv; 2021 Jan; 5(1):89-98. PubMed ID: 33570630
[TBL] [Abstract][Full Text] [Related]
2. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal effect of disease-modifying therapy on left ventricular diastolic function in children with sickle cell anemia.
Rai P; Okhomina VI; Kang G; Martinez HR; Hankins JS; Joshi V
Am J Hematol; 2023 Jun; 98(6):838-847. PubMed ID: 36890729
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.
Desai PC; May RC; Jones SK; Strayhorn D; Caughey M; Hinderliter A; Ataga KI
Br J Haematol; 2013 Sep; 162(6):836-41. PubMed ID: 23829561
[TBL] [Abstract][Full Text] [Related]
5. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.
Morris CR; Kim HY; Trachtenberg F; Wood J; Quinn CT; Sweeters N; Kwiatkowski JL; Thompson AA; Giardina PJ; Boudreaux J; Olivieri NF; Porter JB; Neufeld EJ; Vichinsky EP;
Blood; 2011 Oct; 118(14):3794-802. PubMed ID: 21772051
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.
Forrest S; Kim A; Carbonella J; Pashankar F
Pediatr Blood Cancer; 2012 Jun; 58(6):937-40. PubMed ID: 21990235
[TBL] [Abstract][Full Text] [Related]
9. Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.
Colombatti R; Varotto E; Ricato S; Nardo D; Maschietto N; Teso S; Pillon M; Messina C; Milanesi O; Sainati L
Hematol Rep; 2011 Aug; 3(2):e12. PubMed ID: 22184533
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease.
Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
Br J Haematol; 2009 Mar; 144(5):736-41. PubMed ID: 19055665
[TBL] [Abstract][Full Text] [Related]
11. Echocardiography-derived tricuspid regurgitant jet velocity is an important marker for the progression of sickle-cell disease.
Upadhya B; Stacey RB; Ntim W; Knovich MA; Pu M
Acta Haematol; 2014; 132(2):152-8. PubMed ID: 24577318
[TBL] [Abstract][Full Text] [Related]
12. The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.
Agha H; El Tagui M; El Ghamrawy M; Abdel Hady M
Ann Hematol; 2014 Jul; 93(7):1131-8. PubMed ID: 24562420
[TBL] [Abstract][Full Text] [Related]
13. A prospective appraisal of pulmonary hypertension in children with sickle cell disease.
Sedrak A; Rao SP; Miller ST; Hekmat V; Rao M
J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191
[TBL] [Abstract][Full Text] [Related]
14. Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis.
Srihirun S; Tanjararak N; Chuncharunee S; Sritara P; Kaewvichit R; Fucharoen S; Pattanapanyasat K; Sibmooh N
Thromb Res; 2015 Jan; 135(1):121-6. PubMed ID: 25455999
[TBL] [Abstract][Full Text] [Related]
15. Age is a predictor of a small decrease in lung function in children with sickle cell anemia.
Willen SM; Cohen R; Rodeghier M; Kirkham F; Redline SS; Rosen C; Kirkby J; DeBaun MR
Am J Hematol; 2018 Mar; 93(3):408-415. PubMed ID: 29226507
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in sickle cell disease children under 10 years of age.
Colombatti R; Maschietto N; Varotto E; Grison A; Grazzina N; Meneghello L; Teso S; Carli M; Milanesi O; Sainati L
Br J Haematol; 2010 Sep; 150(5):601-9. PubMed ID: 20553267
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.
El-Shanshory M; Badraia I; Donia A; Abd El-Hameed F; Mabrouk M
Eur J Haematol; 2013 Jul; 91(1):55-61. PubMed ID: 23551575
[TBL] [Abstract][Full Text] [Related]
19. The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.
Cabrita IZ; Mohammed A; Layton M; Ghorashian S; Gilmore A; Cho G; Howard J; Anie KA; Desforges L; Bassett P; Grapsa J; Howard L; Mahalingam G; Dawson D; Pinto FJ; Nihoyannopoulos P; Davies SC; Gibbs JS
Br J Haematol; 2013 Aug; 162(3):400-8. PubMed ID: 23713628
[TBL] [Abstract][Full Text] [Related]
20. Association of elevated tricuspid regurgitation velocity with cerebrovascular and kidney disease in children with sickle cell disease.
Ilonze C; Rai P; Galadanci N; Zahr R; Okhomina VI; Kang G; Padmanabhan D; Lebensburger J; Alishlash AS
Pediatr Blood Cancer; 2024 Jul; 71(7):e31002. PubMed ID: 38644595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
